HUNTINGTON DISEASE
Clinical trials for HUNTINGTON DISEASE explained in plain language.
Never miss a new study
Get alerted when new HUNTINGTON DISEASE trials appear
Sign up with your email to follow new studies for HUNTINGTON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to slow devastating brain disease
Disease control OngoingThis study is testing whether an experimental drug called tominersen can slow down Huntington's disease. It involves 301 people who either have very early symptoms or are at high risk of developing them. The drug is designed to lower the levels of a harmful protein in the brain t…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Huntington's drug gets 4.5-Year safety check
Disease control OngoingThis study is following up on a previous trial to check the long-term safety and effects of the drug votoplam in people with Huntington's disease. It will track 144 participants for an additional 54 months, with everyone now receiving the active drug. The main goals are to monito…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Huntington's drug enters human testing
Disease control OngoingThis early-stage study is testing a new injection called ER2001 in people with early Huntington's disease. The main goals are to check if the treatment is safe, how the body processes it, and to look for early signs it might help. Participants receive weekly injections for 6 week…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE1, PHASE2 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New Huntington's drug enters next safety check
Disease control OngoingThis is a very early study to check the safety of a new drug called ER2001 for people with early Huntington's disease. It will give 9 participants who were in a previous study weekly injections for 6 weeks to see how their bodies handle the drug and if there are any side effects.…
Matched conditions: HUNTINGTON DISEASE
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Can a pill help Huntington's patients speak and walk better?
Disease control OngoingThis study is testing if a medication called deutetrabenazine can help improve speech clarity and walking stability in people with Huntington's disease. Over two years, 30 participants will have their speech and movement carefully measured before and after starting the drug. The …
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Brain injection trial offers hope for halting Huntington's
Disease control OngoingThis early-stage study is testing a one-time gene therapy called AB-1001, delivered directly into the brain, in a small group of adults with early Huntington's disease. The main goals are to see if the treatment is safe and to look for early signs that it might slow the disease. …
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Brainvectis, a subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio) • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC